L Catterton Asia (NASDAQ:LCAA) announced this morning that it has upsized the committed financing in its combination with EV sports car maker Lotus to $870 million in total.
The latest fuel injection comes in the form of $750 million in convertible notes and PIPE commitments under so far undisclosed terms. Counted purely as a PIPE, it would be the largest PIPE in a SPAC deal since CM Life Sciences III secured a $1.2 billion PIPE for its combination with EQRx, which closed in December 2021.
The investors in the upsize have not yet been disclosed, but L Catterton Asia included primarily strategic investors and existing partners in the first $122 million it secured for the PIPE. Altogether, PIPE investors are expected to own about 19% of the combined company at close.
The cash would also seem to help smooth over some early capex hurtles Lotus will need to clear following close. The company notched a net loss of -$377 million in the first half of 2023 as it continues to transition its manufacturing base to producing primarily new EV models rather than its legacy gas-powered luxury and performance vehicles.
Those costs included -$152 million spent on R&D during that period, down from the -$445 million it burned through for such purposes in the 2022, which could indicate its models are approaching greater readiness for the road.
The SPAC, meanwhile, has not yet set a date for a completion vote, but initially aimed for tying up the $5.4 billion transaction before the end of the year when it announced it in January.
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...
In June 2025, the SPAC market was marked by a notable rise in meeting delays, with adjournments and postponements playing a central role in extension activity, as sponsors navigated a more cautious market environment. Still, several SPACs secured shareholder approvals, and seven business combinations were completed during the month. At the same time, IPO issuance...
An In-Depth Look at SPAC Activity Through the Second Quarter & First Half 2025 Below is a summary of the first half of 2025 SPAC market. If you’d like a pdf copy, you can access the link HERE. Q2 kicked off in chaos. President Trump’s shifting and often contradictory tariff announcements sent markets reeling, driving...
At the SPAC of Dawn The market is set to be showered with new SPACs today as three more SPACs priced their IPOs overnight, bringing 2025’s total to 66, already surpassing the full-year total of 2024. After hours, Ribbon (NASDAQ:RIBB) also added a new SPAC deal to June’s tally just under the wire, bringing the...
NMP Acquisition Corp. (NASDAQ:NMPAU) announced the pricing of its $100 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “NMPAU”, Tuesday, July 1, 2025. The new SPAC plans to combine with a target company that has a resilient business model with potential to scale up revenue. NMP’s management...